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PRELIMINARY AND SHORT REPORTS
A FIXED ERUPTION DUE TO BROMIDES*
JESSE A. TOLMACH, M.D. AND SAMUEL B. FEANK, M.D.
Since the introduction of the term "fixed eruption" by Louis Broeq (1) many drugs and
agents bave been described as capable of prodncing this characteristic form of dermatosis.
As compiled by Abramowitz and Noun (2), by Abramowitz (3), and by Sulzberger (4), the
comprehensive list of materials able to produce this eruption does not include bromides.
A search of the literature has not revealed any instance in which bromides have been identi-
fied as a cause of a fixed eruption. Abramowitz (3) described a fixed eruption as one that
recurs in the primarily affected area each time the drug or other agent is used. "Such
lesions appear usually as erythematous, pigmentary or erythematous vesiculo-bullous
patches."
The following report illustrates an example of a characteristic erythematous, vesico-
bullous type of fixed eruption following the ingestion of bromides.
Case Report: F. C., a white woman, aged 52, was observed by us for the first time on
December 29th, 1947. She presented an eruption on the anterior surface of the right leg.
The patient stated that a similar eruption had appeared in the same site in January, 1947,
first appearing as an oozing area about inch in diameter and spreading in three weeks to an
area roughly 4 inches in diameter. This was the first time she had experienced an eruption
of such a type. The condition improved and flared np during a period of three months.
On inquiry as to the ingestion of medications, it was revealed that a product called Neuro-
sine1 was prescribed by her family physician early in December, 1946, for a nervous con-
dition. On cessation of the ingestion of Neurosine the eruption on her leg healed, leaving
a persistent pigmented area. A lesion recurred at the same site on December 23, 1947,
covering the entire area. The patient had resumed taking Neurosine about 7 days
before the eruption appeared. Examination on December 29th, 1947, revealed isolated
and confluent vesieles and bullae, some containing a clear, and others, a hemorrhagic fluid
on a waxy, erythematous, pigmented, roughly circular background about 4k inches in
diameter. The bases of ruptured vesieles gave the appearance of granulation tissue.
This lesion cleared up in about three to four weeks with boric acid compresses and a simple
zinc oxide lotion. A bluish-brown, shiny, pigmentation of the original site remained.
The results of serologic tests for syphilis and a hemogram taken at this time were normal.
According to Dr. Else A. Barthel, histologic examination of a biopsy specimen taken from
this residual skin change on February 2, 1948, revealed the following: Section shows a thin
epidermis that is relatively normal and covered by a thick, non-parakeratotie scale. The
blood vessels are slightly dilated. The endothelial linings are swollen in some of the
vessels. Other vessels show a thickening of the walls. The nuclei in the collagen fibres are
prominent. The Perl stain is negative. Stains for fats and lipoids show no definite ab-
normalities. Microscopic Diagnosis: Dermatitis.
On February 5, 1948, the patient was given triple bromides2 in doses of one tablet, three
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Neurosine contains per fluid ounce; sodium bromide 30 grains, potassium bromide 30
grains, ammonium bromide 30 grains, zinc bromide 3/5 grain, extract hyoseyamus (henbane)
3/40 grain, fluid extract belladonna leaf 3/40 minim, fluid extract cascara sagrada 3/5
minim, extract humulus (1:3) 3/5 grain in a liquid vehicle. One teaspoonful contains
approximately ll grains of the combined bromides.
2 Three Bromide Tablets contain: ammonium bromide, potassium bromide, and sodium
bromide. A tablet contains 0.3 gm. each of each bromide.
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times daily and was advised to discontinue the medication if the eruption recurred. Nine
days after the bromide medication was instituted, vesieles appeared within the original
fixed area. The first reaction occurred in the healing site where tissue had been removed
for histologic examination. The medication was stopped. Vesicles covered the entire
area within four days, reproducing the picture seen originally. When seen three weeks
later the area was healing.
On May 7th, 1948, the originally described area of pigmented, shiny skin was observed.
In view of the fact that vesicles first appeared within the fixed area where the skin had been
traumatized for the tissue examination, it was considered of interest to repeat exposure to
bromides after traumatizing skin outside of the original area. Bloch and Tenchio (5) re-
ported that they had been able to reproduce a pustular bremoderma by traumatizing the
normal skin of a patient with a wide-spread pustular bromoderma. Therefore, on the un-
involved left leg, an area of normal skin, 5 by 10 mm., was scarified with a scalpel. Pro-
caine anesthesia was used. Another area of uninvolved skin, about 4 mm. by 8 mm. in size,
about 2 cm. distant from the original site en the right leg, was excised under procaine
anesthesia. On the same day, ingestion of Elixir Bromide N. F.3 was started in doses of one
teaspoonful, three times daily. After taking the medication seven days, renewed vesicular
activity recurred at the site of the original fixed eruption; the traumatized areas were
crusted and appeared to he healing. Five days later the original site was completely
covered with vesicles; the scarified area and the excision scar both showed moderate cry-
thema and definite palpable induration. The zone of erythema and induration of the
scarified and excised sites persisted for one week. At the end of two weeks, the original site
was healing and the traumatized sites were normal again. We would have liked to repeat
the scarification during a period when the patient was not taking bromides, as a control,
but the patient did not return for further investigation.
sUMMARY
(1) A ease of fixed eruption due to bromides is reported. This is, to the best of our
knowledge, the first reported case of fixed eruption due to bromides.
(2) Contrary to the usual experience with fixed eruptions, the eruption appeared after
approximately eight days of ingestion of bromides.
(3) At the site of trauma of previously uninvolved skin, an erythematous, indurated
reaction was produced by the ingestion of bromides. Although the original type of lesion
was not reproduced, the type of reaction elicited warrants further investigation in other
eases of fixed eruption.
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Three Bromides Elixir contain: ammonium bromide SO gm., potassium bromide SO
gm., sodium bromide SO gm., amaranth solution 3 cc, compound benzaldehyde elixir, a
sufficient quantity to make 1000 cc. Four cc equals 0.32 gm. each of each bromide.
